EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class…
Medit Launches a New All-on-X Solution, Medit SmartX
SEOUL, South Korea and NEWPORT BEACH, Calif., March 18, 2025 /PRNewswire/ -- Medit…
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Polyrizon Signs Non Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
March 14, 2025 08:35 ET | Source: Polyrizon Ltd. Raanana, Israel, March…
XRP Whales Take Massove Positions In XRPTurbos Token Launch As Ripple Vs. SEC Case Nears Resolution
TALLINN, Estonia, March 12, 2025 (GLOBE NEWSWIRE) -- The XRP community is…
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”)…
Dupixent (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36…
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor…
FARMLORE IN BENGALURU IS UNVEILED AS THE WINNER OF THE AMERICAN EXPRESS ONE TO WATCH AWARD 2025 AS PART OF ASIA’S 50 BEST RESTAURANTS
LONDON, March 6, 2025 /PRNewswire/ -- Farmlore in Bengaluru has been honoured as…
Collective efforts needed between partners to use the potential of sport to achieve the SDGs
03 March 2025 - Joining the 2025 Finance in Common Summit (FiCS), the…
